Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The schizophrenia PORT pharmacological treatment recommendations: conformance and implications for symptoms and functional outcome Buchanan RW; Kreyenbuhl J; Zito JM; Lehman ASchizophr Bull 2002[]; 28 (1): 63-73This cross-sectional study examines conformance to four of the Schizophrenia Patient Outcomes Research Team (PORT) antipsychotic treatment recommendations, patient and treatment setting characteristics assocated with conformance, and the relationship of conformance with outcome. Two hundred twenty-four inpatients and 358 outpatients with schizophrenia underwent an interview and review of their medical records. Demographic, clinical, and role function data were collected. Almost all inpatients and outpatients with schizophrenia or schizoaffective disorder were prescribed an antipsychotic. The majority of inpatients were prescribed an antipsychotic within the recommended dose range, whereas the majority of outpatients were prescribed an antipsychotic either below or above the recommended dose range. There were no consistent relationships between patient, geographic, and treatment characteristics and antipsychotic dose. Patients treated with conventional antipsychotic doses below the recommended dose range had significantly better role function. Prospective longitudinal studies are required to delineate the factors that may underlie this relationship.|*Schizophrenic Psychology[MESH]|Adult[MESH]|Antipsychotic Agents/adverse effects/*therapeutic use[MESH]|Critical Pathways[MESH]|Cross-Sectional Studies[MESH]|Dose-Response Relationship, Drug[MESH]|Female[MESH]|Humans[MESH]|Male[MESH]|Middle Aged[MESH]|Psychiatric Status Rating Scales[MESH]|Psychotic Disorders/diagnosis/*drug therapy/psychology[MESH]|Schizophrenia/diagnosis/*drug therapy[MESH]|Social Adjustment[MESH]|Treatment Outcome[MESH]|United States[MESH] |